Salisbury NHS Foundation Trust

NHS Foundation Trust

Expenditure

Monthly

High Spend Suppliers

Total: £501.3M
479
Suppliers
£1M
Avg spend
23.8%
Top 3 share
Supplier Total spend
  1. SUPPLY CHAIN COORDINATION LIMITED
    £59.2M
    11.8% share
  2. SALISBURY HEALTHCARE FACILITIES LIMITED
    £31.9M
    6.4% share
  3. BAM CONSTRUCTION LIMITED
    £28M
    5.6% share
  4. LLOYDS PHARMACY LTD
    £13.7M
    2.7% share
  5. ASSET PLUS ENERGY PERFORMANCE LTD
    £12.8M
    2.6% share
  6. L ROWLAND & CO LTD
    £12.7M
    2.5% share
  7. ID MEDICAL GROUP LIMITED
    £11.7M
    2.3% share
  8. TOTALENERGIES GAS & POWER LIMITED
    £11.3M
    2.2% share
  9. LP HCS LIMITED
    £10.6M
    2.1% share
  10. INLAND REVENUE CIS
    £10.4M
    2.1% share
View all suppliers → View all contracts →

Top Expense Areas

2026-01-01 to 2026-05-31

  1. 1

    Balance Sheet

    £34M

  2. 2

    PHARMACY OUTPATIENTS - LLOYDS PHARMACY PROJECT

    £3.8M

  3. 3

    ENERGY AND WATER SDH

    £2.6M

  4. 4

    FINANCING CHARGES

    £2.2M

  5. 5

    CLINICAL ORTHOPAEDICS

    £1.8M

Top Expense Types

2026-01-01 to 2026-05-31

  1. 1

    Asset Addition Clearing Code

    £22.7M

  2. 2

    Drugs

    £6.1M

  3. 3

    Purch Tang FA Addns Gr

    £3.7M

  4. 4

    Misc Hospital Supplies

    £3.7M

  5. 5

    Hcare Srv Rec Other NHS

    £3.3M

Recent Payments Out
Date Supplier Amount Expense Area Expense Type
2026-05-31
£67,925 DERMATOLOGY OP Contractual Clinical Srv
2026-05-31
£28,477 DERMATOLOGY OP Contractual Clinical Srv
2026-05-31
£125,518 CLINICAL GASTROENTEROLOGY Contractual Clinical Srv
2026-05-31
£116,764 CLINICAL GASTROENTEROLOGY Contractual Clinical Srv
2026-05-31
£25,344 Balance Sheet Other Liabilities - Curr
2026-05-31
£35,251 Balance Sheet Drugs
2026-05-31
£29,190 FINANCIAL ACCOUNTING Audit Fees: Internal
2026-05-31
£923,577 PHARMACY OUTPATIENTS - LLOYDS PHARMACY PROJECT Drugs
2026-05-31
£30,096 GWH PROCUREMENT Med & Surg Equip Repair
2026-05-31
£26,250 PROCUREMENT Services Received - NHSTs
2026-05-31
£74,760 Balance Sheet Asset Addition Clearing Code
2026-05-31
£30,667 MANAGEMENT FAMILY AND SPECIALIST SERVICES Contractual Clinical Srv
2026-05-31
£34,312 CLINICAL UROLOGY Outsourced Services from Non NHS Provider
2026-05-31
£26,645 CLINICAL UROLOGY Outsourced Services from Non NHS Provider
2026-05-31
£43,841 Balance Sheet Drugs
2026-05-31
£142,709 Balance Sheet Asset Addition Clearing Code
2026-05-31
£138,000 Balance Sheet Asset Addition Clearing Code
2026-05-31
£81,441 Balance Sheet Asset Addition Clearing Code
2026-05-31
£69,559 Balance Sheet Drugs
2026-05-31
£45,134 Balance Sheet Drugs

Showing 21 to 40 of 267531 transactions

Recent Payments In
Date Buyer Amount Expense Area Expense Type
2026-02-02
£1,203,000 Finance Additions NCB PDC
Additions NCB PDC
2026-01-27
£32,031 Science and Research Research & development
Research Capability Funding - Standard
2026-01-27
£32,031 Science and Research Research & development
Research Capability Funding - Standard
2026-01-19
£2,114,000 Finance Additions NCB PDC
Additions NCB PDC
2026-01-19
£2,051,000 Finance Additions NCB PDC
Additions NCB PDC
2026-01-19
£150,000 Finance Additions NCB PDC
Additions NCB PDC
2026-01-19
£2,114,000 Finance Additions NCB PDC
Additions NCB PDC
2026-01-19
£210,000 Finance Additions NCB PDC
Additions NCB PDC
2026-01-19
£2,051,000 Finance Additions NCB PDC
Additions NCB PDC
2026-01-19
£210,000 Finance Additions NCB PDC
Additions NCB PDC
2026-01-19
£150,000 Finance Additions NCB PDC
Additions NCB PDC
2025-11-10
£191,000 Finance Additions NCB PDC
Additions NCB PDC
2025-11-03
£342,000 Finance Additions NCB PDC
Additions NCB PDC
2025-09-25
£111,495 Science and Research Research & development
EME Researcher Led
2025-09-25
£32,030 Science and Research Research & development
Research Capability Funding - Standard
2025-09-15
-£2,315,000 Finance Dividends receivable on PDC
Dividends receivable on PDC
2025-06-30
£32,030 Chief Scientific Adviser Research & development
Research Capability Funding - Standard
2025-06-25
£111,495 Chief Scientific Adviser Research & development
EME Researcher Led
2025-05-19
-£319,200 Finance Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan
Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan
2025-03-20
£107,009 Chief Scientific Adviser Research & development
EME Researcher Led

Showing 21 to 40 of 925 transactions

Frequently Asked Questions

What is the latest spending data available for Salisbury NHS Foundation Trust?

The most recent spending data we have available for Salisbury NHS Foundation Trust is from May 2026. Government departments and public bodies typically publish their spending data on a monthly or quarterly basis.

How has Salisbury NHS Foundation Trust's spending changed over time?

Salisbury NHS Foundation Trust's spending has decreased over time. In 2026, they spent £57,080,182, compared to £84,891,272 in 2025 - a decrease of 32.8%.

How much does Salisbury NHS Foundation Trust spend on suppliers?

Salisbury NHS Foundation Trust has spent a total of £501,286,594 on suppliers according to our records. This spending is distributed across 479 suppliers.